BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18646656)

  • 1. [Sentinel lymph node biopsy in the breast carcinoma in clinical practice].
    Gatek J; Hnátek L; Dudesek B; Vázan P; Bakala J; Hradská K; Kotoc J; Musil T; Duben J
    Rozhl Chir; 2008 Apr; 87(4):180-5. PubMed ID: 18646656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE;
    Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sentinel lymphatic node biopsy for breast cancer in practice].
    Strnad P; Rob L; Krízová H; Zuntová A; Chod J; Halaska M
    Ceska Gynekol; 2005 Jul; 70(4):291-5. PubMed ID: 16128130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
    Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
    Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer.
    Parmar V; Hawaldar R; Nair NS; Shet T; Vanmali V; Desai S; Gupta S; Rangrajan V; Mittra I; Badwe RA
    Breast; 2013 Dec; 22(6):1081-6. PubMed ID: 23948301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Exclusive use of blue dye to detect sentinel lymph nodes in breast cancer].
    Bühler H S; Rojas P H; Cayazzo M D; Cunill C E; Vesperinas A G; Hamilton S J
    Rev Med Chil; 2008 Aug; 136(8):1015-20. PubMed ID: 18949185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study comparing the accuracy of lymphoscintigraphy sentinel lymph node localisation with axillary node dissection in women with operable breast cancer.
    Allen B; Campbell I; Desai S; Dray M; Scarlet J
    N Z Med J; 2001 May; 114(1132):233-6. PubMed ID: 11453361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Demonstration of the sentinel lymph node in axillary dissection for breast cancer].
    Salmon RJ; Fried D
    Presse Med; 1998 Mar; 27(11):509-12. PubMed ID: 9767960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative palpation for clinically suspicious axillary sentinel lymph nodes reduces the false-negative rate of sentinel lymph node biopsy in breast cancer.
    Carmon M; Olsha O; Rivkin L; Spira RM; Golomb E
    Breast J; 2006; 12(3):199-201. PubMed ID: 16684315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical practice guidelines for the use of axillary sentinel lymph node biopsy in carcinoma of the breast: current update.
    Schwartz GF
    Breast J; 2004; 10(2):85-8. PubMed ID: 15009032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
    Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
    J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy.
    Intra M; Trifirò G; Viale G; Rotmensz N; Gentilini OD; Soteldo J; Galimberti V; Veronesi P; Luini A; Paganelli G; Veronesi U
    Ann Surg Oncol; 2005 Nov; 12(11):895-9. PubMed ID: 16195833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Axillary recurrences after sentinel lymph node biopsy in initial breast cancer].
    Sampol C; Giménez M; Torrecabota J; Serra C; Canet R; Daumal J; Peña C; Gonzalez L; Hernandez E; Graner A; Pozo A; Vega F
    Rev Esp Med Nucl; 2010; 29(5):241-5. PubMed ID: 20466461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?
    Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N
    Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved false negative rate of axillary status using sentinel lymph node biopsy and ultrasound-suspicious lymph node sampling in patients with early breast cancer.
    Wang Y; Dong H; Wu H; Zhang L; Yuan K; Chen H; Jiao M; Fu R
    BMC Cancer; 2015 May; 15():382. PubMed ID: 25956308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of the lymphoscintigraphy in the evaluation of non-axillary sentinel lymph node localization in breast cancer.
    Gherghe M; Bordea C; Blidaru A
    Chirurgia (Bucur); 2015; 110(1):26-32. PubMed ID: 25800312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-probe-guided resection of the sentinel lymph node in breast cancer.
    Crossin JA; Johnson AC; Stewart PB; Turner WW
    Am Surg; 1998 Jul; 64(7):666-8; discussion 669. PubMed ID: 9655279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of immediate preoperative injection of radiopharmaceutical and blue dye for sentinel node biopsy in patients with breast cancer.
    Dixon JM; Mak C; Radhakrishna S; Kehoe T; Millar AM; Wong D; Thomas JS
    Eur J Cancer; 2009 Mar; 45(5):795-9. PubMed ID: 19101140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sentinel lymph node biopsy in breast cancer. Experience of the Rome Breast Cancer Study Group].
    Fortunato L; Drago S; Vitelli CE; Santoni M; Gucciardo G; Cabassi A; Farina M; La Pinta M; Remedi M; Pagano G; Silipod T; Terribile D; Stagnitto D; Grassi GB;
    Chir Ital; 2006; 58(6):689-96. PubMed ID: 17190273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial experience in a cancer hospital in Nepal with sentinel lymph node mapping and biopsy for evaluation of axillary lymph node status in palpable invasive breast cancer.
    Lamichhane N; Pradhan M; Neupane PR; Shrestha BM; Dhakal HP; Thakur BK; Cox CE
    Nepal Med Coll J; 2007 Mar; 9(1):22-6. PubMed ID: 17593673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.